Ceftriaxone Injection, Powder, For Solution
Product Images NDC 0143-9859
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ceftriaxone (NDC 0143-9859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ndc 0143-9859-01 Rx Only Ceftriaxone For Injection, Usp 250 mg/vial Equivalent To 250 mg Ceftriaxone For Iv Or Im Use Single Dose Vial Protect From Light A 350 mg/ml Concentration Is Not Recom- Mended For The 250 mg Vial Since It May Not Be Possible To Withdraw The Entire Contents. For Iv Or Im Administration And Usual Dosage: See Package Insert. Storage Prior To Reconstitution: Store Powder At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Storage After Reconstitution: See Package Insert. (Ceftriaxone For Injection 2)
Ndc 0143-9858-01 Rx Only Ceftriaxone For Injection, Usp 500 mg/vial Equivalent To 500 mg Ceftriaxone For Iv Or Im Use Single Dose Vial Protect From Light For Im Administration: Reconstitute With 1 mL 1% Lidocaine Hydrochloride Injection, Usp Or Sterile Water For Injection, Usp. Each 1 mL Of Solution Con- Tains Approximately 350 mg Equivalent Of Ceftriaxone. For Iv Administration: Reconstitute With 4.8 mL Of An Iv Diluent Specified In The Accompanying Package Insert. Each 1 mL Of Solution Contains Approximately 100 mg Equivalent Of Ceftriaxone. Withdraw Entire Contents And Dilute To The Desired Concentration With The Appropriate Iv Diluent. Usual Dosage And Storage After Reconstitution: See Package Insert. storage Prior To Reconstitution: Store Powder At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. (Ceftriaxone For Injection 3)
Ndc 0143-9857-01 Rx Only Ceftriaxone For Injection, Usp 1 Gram/vial Equivalent To 1 Gram Ceftriaxone For Iv Or Im Use Single Dose Vial Protect From Light For Im Administration: Reconstitute With 2.1 mL 1% Lidocaine Hydrochloride Injection, Usp Or Sterile Water For Injection, Usp. Each 1 mL Of Solution Con- Tains Approximately 350 mg Equivalent Of Ceftriaxone. For Iv Administration: Reconstitute With 9.6 mL Of An Iv Diluent Specified In The Accompanying Package Insert. Each 1 mL Of Solution Contains Approximately 100 mg Equivalent Of Ceftriaxone. Withdraw Entire Contents And Dilute To The Desired Concentration With The Appropriate Iv Diluent. Usual Dosage And Storage After Reconstitution: See Package Insert. Storage Prior To Reconstitution: Store Powder At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. (Ceftriaxone For Injection 4)
Ndc 0143-9856-01 Rx Only Ceftriaxone For Injection, Usp 2 Grams/vial Equivalent To 2 Grams Ceftriaxone For Iv Or Im Use Single Dose Vial Protect From Light For Im Administration: Reconstitute With 4.2 mL 1% Lidocaine Hydrochloride Injection, Usp Or Sterile Water For Injection, Usp. Each 1 mL Of Solution Con- Tains Approximately 350 mg Equivalent Of Ceftriaxone. For Iv Administration: Reconstitute With 19.2 mL Of An Iv Diluent Specified In The Accompanying Package Insert. Each 1 mL Of Solutin Contains Approximately 100 mg Equivalent Of Ceftriaxone. Withdraw Entire Contents And Dilute To The Desired Concentration With The Appropriate Iv Diluent. Usual Dosage And Storage After Reconstitution: See Package Insert. Storage Prior To Reconstitution: Store Powder At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. (Ceftriaxone For Injection 5)
Ceftriaxone For Injection 6
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.